Italy’s demographic crisis is often painted as a looming disaster, but for some visionary entrepreneurs, it’s a goldmine of opportunity. While policymakers wring their hands over an aging population, a handful of Italian companies are thriving by catering to the needs of the elderly—and even the youngest generations.
Take Sergio and Massimo Bariani, for instance. Two decades ago, these Milan-based brothers built their first senior living facility, despite widespread skepticism. Italians, after all, are famously attached to their homes. But within months, their 120-bed facility was full. Fast forward to today, and their company, Gruppo Gheron, operates 36 state-of-the-art care homes in northern Italy, employs over 1,500 people, and raked in €152 million last year. With seven new facilities and 1,000 additional beds on the horizon, they’re just getting started. But here’s where it gets controversial: Can Italy’s labor market keep up with this demand, especially with restrictive migration policies in place?
Alessandro Bariani, the group’s CFO and son of one of the founders, puts it bluntly: “There’s a massive demand for nursing home beds.” With nearly a quarter of Italy’s 59 million people over 65, the country has one of Europe’s oldest populations. While this is often seen as a burden on the economy, companies like Gruppo Gheron are turning it into a booming business. But this is the part most people miss: Italy has only 21 long-term care beds per 1,000 seniors, compared to 54 in Germany and 47 in France. That’s a staggering gap—and a massive opportunity.
Yet, it’s not just about senior care. Rita Paola Petrelli, chair of Kolinpharma, a nutraceutical company, is tapping into the growing demand for health supplements. Founded in 2013, Kolinpharma uses natural ingredients like turmeric, saffron, and green tea to create products targeting age-related issues such as joint pain, cognitive decline, and even Parkinson’s disease. With €19 million in sales last year, Petrelli is clear: “We want to improve the quality of life for both patients and caregivers.” But is this just a trend, or a sustainable solution for an aging population?
Meanwhile, companies like Gallas Group are revolutionizing home care. A decade ago, most domestic workers in Italy were part of the shadow economy, facing exploitation and unreliable employment. Today, Gallas Group operates in 50 cities, connecting 13,000 families with live-in carers. With a turnover of nearly €11 million in 2024, they’ve formalized a sector once plagued by informality. Yet, Giorgia Gollino, head of HR, admits: “The shortage of caregivers, especially from abroad, is our biggest challenge.”
And then there’s Ames Group, which is thriving despite Italy’s declining birth rate. Specializing in non-invasive prenatal testing, Ames allows expectant parents to check their baby’s health early in pregnancy. In a country with just 370,000 births last year, Ames conducted 40,000 tests, generating €40 million in revenue. Nello De Rosa, the CFO, explains: “When families have fewer children, they’re willing to invest more in their health.” But is this focus on prenatal care a bandaid solution, or a glimpse into the future of healthcare?
Italy’s demographic crisis is undeniably complex. While some see it as a burden, others are turning it into a business opportunity. But here’s the real question: Are these companies truly addressing the root of the problem, or simply profiting from it? What do you think? Is Italy’s aging population a crisis—or a chance to innovate? Let’s debate in the comments.
